European Commission Approves Once-Weekly Etanercept for Psoriasis

The European Commission has approved etanercept (Enbrel) 50 mg once-weekly dosage regimen as an alternative to the currently approved etanercept 25 mg twice-weekly regimen for the treatment of patients with moderate to severe plaque psoriasis.
Doctor’s Guide